Skip to main content

PBMS

Pharmacy Review Expertise PBMs Choose with Confidence

Formulary-aligned pharmacy reviews that protect margin and member outcomes.

Learn More

We Support Your Clients, Providers, and Members

Payers frequently struggle with controlling drug spend and staying compliant amid a constantly evolving regulatory environment. MRIoA's clinical reviews support regulatory adherence while delivering precise, timely pharmacy decisions.

Clinical teams at PBMs face fluctuating PA and appeal volumes, time-sensitive turnaround requirements, complex specialty and rare-disease requests, and constant program changes due to fast-tracked drug approvals.

MRIoA brings licensed clinicians and pharmacy experts, proven intake workflows, and scalable capacity to help you reduce administrative burden, improve decision consistency, and strengthen compliance—while ensuring members get the right therapy at the right time.

Designed for the Operational Reality of PBMs

  • Your clinical criteria, drug policies, and formulary structure are applied to reviews, ensuring every determination reflects your program design, including high-demand medications like GLP-1s
  • Available capacity to meet fluctuating prior authorization and appeal demand without increasing fixed internal costs
  • Specialty-matched reviewers strengthen defensibility and reduce overturn risk
  • Licensed pharmacists and physicians review high-cost drugs, gene therapies, and rare disease treatments with rigorous documentation that determines appropriateness or if exception to the criteria is supported
  • Workflows that align with state and federal regulations, including Medicare Part D requirements and evolving state mandates

Pharmacy Reviews Configured for Your Lines of Business

MRIoA configures pharmacy review services to fit the unique requirements of each line of business you manage.

How PBMs Partner with MRIoA

We provide scalable clinical resources for rapid integration into your workflows to handle even the highest review volumes.

Pharmacy Reviews
Pharmacy Reviews

Our multidisciplinary team of pharmacy technicians, pharmacists, physicians and specialists manage initial reviews, first- and second-level reviews, peer-to-peer reviews, and external reviews.

High-Cost Specialty Drug Reviews
High-Cost Specialty Drug Reviews

Our board-certified physician specialists review high-cost drug requests for complex conditions and rare diseases.

Pharmacy & Therapeutics (P&T) Committee
Pharmacy & Therapeutics (P&T) Committee

Our experts evaluate drug policies, review criteria, and conduct clinical evaluation while providing full P&T Committee support.

Built for Timeliness, Quality, and Clinical Rigor

MRIoA’s pharmacy review services give PBMs clinical depth, access to same-state licensed specialists, and high-quality reviews.

Pharmacy-Specific Clinical Depth

Reduce the strain on your internal clinical team by accessing MRIoA’s extensive clinical resources to seamlessly scale as volume and case complexity shift.

Fast, Reliable Turnaround Times

Meet time-sensitive prior authorization and appeal timelines while reducing delays that impact therapy initiation.

Complex Case Reviews

Count on MRIoA’s specialist expertise for clinically complex, rare diseases, or ultra-high-cost specialty drug reviews.

Improved Clinical Outcomes

We mirror your clinical review philosophy, so our reviews will always align with your policies and review processes.

Cost Savings

MRIoA’s specialist reviewers assess site-of-care optimization, therapeutic interchange, and dose optimization.

Program & Regulatory Readiness

We ensure compliance with even the most rigorous state legislative requirements.

Perspectives for PBMs

Blog
03/25/2026

4 Best Practices to Get Better Outcomes and Better Member Experiences

Outsourcing utilization management (UM) used to be a “break glass in case of overflow” decision. Outsourcing served as a response to volume fluctuations, staffing shortages, or when an independent review…
Blog
01/29/2026

From Policy to Practice: What Today’s Regulatory Shifts Mean for Clinical and Pharmacy Operations

Regulatory change is no longer episodic. It is cumulative, layered, and increasingly operational. Legislative and regulatory shifts are moving quickly from Capitol Hill and state capitols into day-to-day operations. For…
Blog
09/29/2025

Is your Organization Ready for Fall 2025 State Regulatory Changes? 

State legislatures and regulators are moving fast, and for payers, third-party administrators (TPAs), and pharmacy benefit managers (PBMs), the business impact is real. Starting this fall and continuing into early…

Deliver Pharmacy Decisions with Confidence

Connect with our team to strengthen your pharmacy review infrastructure and specialty drug governance.